Insights · August 5, 2026
Claims can flag an impossible billing pattern. They still cannot confirm whether a behavioral health session happened.
Three federal signals made the documentation gap harder to ignore this year. Analytics caught the impossibility. Claims data still could not prove the sessions occurred.
Separate federal bodies publicly confirmed the same problem: claims and prescriptions get filed, but whether the non-drug care behind them happened is rarely provable.
DOJ
Enforcement at scale
The takedown was not only opioid and telemedicine theater. Billing volume without a credible session footprint is now a public enforcement story. Program integrity teams already knew the pattern; the record made the stakes explicit.
CMS · SAMHSA · HRSA · ACF
May 4, 2026 letter
A joint Dear Colleague Letter directs the field toward evidence-based nonmedication treatment grounded in informed consent and shared decision-making. CMS issued same-day deprescribing guidance. The pressure is documentation — not any vendor product.
OIG
Two active 2026 reviews
Medicare payments for Spravato under FWA billing scrutiny, plus foster-care psychotropic treatment planning and monitoring. Different populations. Same question: what was documented about the care around the claim?
None of this means CMS has reviewed or validated any particular product. It means the federal record now treats “was the session documented as real care?” as an open, urgent question — not a niche compliance footnote.
Program integrity work is strong on impossible volume and coverage mismatches. It is weaker when the question is quieter: did a consented behavioral health session actually take place?
What claims show
What claims miss
That is not a call for another fraud-scoring dashboard. It is a call for a second source of session evidence that a clinician can review or dismiss — and that a payer or TPA can evaluate under their own process.
A session physiology documentation layer — not an FWA tool, not a CMS-endorsed product. Something stronger than a claim line when the question is whether care occurred.
Post-session wearable heart-rate signal and vocal biomarkers, fused into structured evidence alongside the clinical record.
Clinicians review or dismiss. Payers and program integrity offices use the record under their own process.
No medical-necessity determination. No claim of catching fraud. The honest job is documentation that survives scrutiny.
How session physiology fits program integrity → Request access →
For payer, TPA, and program integrity teams evaluating a documentation layer.